Skip to main content
Top
Published in: Journal of Orthopaedic Surgery and Research 1/2015

Open Access 01-12-2015 | Research article

Warfarin cessation is non-essential in patients undergoing total knee arthroplasty—a case-control study

Authors: Alfred Phillips, Michael Dan, Nathan Schaefer, Raymond Randle

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2015

Login to get access

Abstract

Background

Warfarinised patients frequently present for total knee arthroplasty (TKA). Current practice of heparin ‘bridging’ is potentially cumbersome and hazardous. The research question is if cessation of warfarin is necessary for TKA.

Methods

The study design was a retrospective case–control series of 61 warfarinised patients and 61 control patients undergoing TKA. TKA was performed by the senior author using a medial parapatellar approach without tourniquet. The target perioperative international normalised ratio (INR) for warfarinised patients was 2–2.2. Primary outcomes were changes in haemoglobin, transfusion requirements and complication rates.

Results

There was no statistically significant difference between control and warfarin group in mean perioperative Hb (g/L) (pre-op 140 vs 141, day 0 115 vs 115, day 1 108 vs 111, P = 0.63), transfusion rates (14.75% vs 9.83%, P = 0.58), total complication rate (9.8% vs 9.8%, P = 0.75), demographics, range of motion or length of stay. There was a statistically significant higher use of the re-infusion drain in the warfarinised group (47.5% vs 24.6%, P = 0.014).

Conclusion

This study supports the hypothesis that warfarin cessation is non-essential in patients undergoing TKA. This data is applicable to a patient group using re-infusion drains. Limitations of this study are typical of a small non-controlled observational study.
Literature
1.
go back to reference Australian Orthopaedic Association National Joint Replacement Registry. Annual Report. In Book Australian Orthopaedic Association National Joint Replacement Registry. Annual Report. Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR); 2013. Australian Orthopaedic Association National Joint Replacement Registry. Annual Report. In Book Australian Orthopaedic Association National Joint Replacement Registry. Annual Report. Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR); 2013.
2.
go back to reference Turrentine FE, Wang H, Simpson VB, Jones RS. Surgical risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg. 2006;203:865–77.PubMedCrossRef Turrentine FE, Wang H, Simpson VB, Jones RS. Surgical risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg. 2006;203:865–77.PubMedCrossRef
3.
go back to reference Grant PJ, Brotman DJ, Jaffer AK. Perioperative anticoagulant management. Anesthesiol Clin. 2009;27:761–77.PubMedCrossRef Grant PJ, Brotman DJ, Jaffer AK. Perioperative anticoagulant management. Anesthesiol Clin. 2009;27:761–77.PubMedCrossRef
4.
go back to reference Kurtz SM, Ong KL, Schmier J, Mowat F, Saleh K, Dybvik E, et al. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am. 2007;89 Suppl 3:144–51.PubMedCrossRef Kurtz SM, Ong KL, Schmier J, Mowat F, Saleh K, Dybvik E, et al. Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg Am. 2007;89 Suppl 3:144–51.PubMedCrossRef
5.
go back to reference Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–5.PubMedCrossRef Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–5.PubMedCrossRef
6.
go back to reference Weiss P, Soff GA, Halkin H, Seligsohn U. Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy. Thromb Res. 1987;45:783–90.PubMedCrossRef Weiss P, Soff GA, Halkin H, Seligsohn U. Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy. Thromb Res. 1987;45:783–90.PubMedCrossRef
7.
go back to reference Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ, American College of Chest Physicians Antithrombotic T, Prevention of Thrombosis P. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:7S–47.PubMedCentralPubMedCrossRef Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ, American College of Chest Physicians Antithrombotic T, Prevention of Thrombosis P. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141:7S–47.PubMedCentralPubMedCrossRef
8.
go back to reference Blacker DJ. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust. 2005;182:365. author reply 367–368.PubMed Blacker DJ. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust. 2005;182:365. author reply 367–368.PubMed
9.
go back to reference Wahl MJ. Myths of dental surgery in patients receiving anticoagulant therapy. J Am Dent Assoc. 2000;131:77–81.PubMedCrossRef Wahl MJ. Myths of dental surgery in patients receiving anticoagulant therapy. J Am Dent Assoc. 2000;131:77–81.PubMedCrossRef
10.
go back to reference Blacker DJ, Wijdicks EF, McClelland RL. Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology. 2003;61:964–8.PubMedCrossRef Blacker DJ, Wijdicks EF, McClelland RL. Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy. Neurology. 2003;61:964–8.PubMedCrossRef
11.
go back to reference Poller L, Thomson J. Evidence for “rebound” hypercoagulability after stopping anticoagulants. Lancet. 1964;2:62–4.PubMedCrossRef Poller L, Thomson J. Evidence for “rebound” hypercoagulability after stopping anticoagulants. Lancet. 1964;2:62–4.PubMedCrossRef
12.
go back to reference Wallace DL, Latimer MD, Belcher HJ. Stopping warfarin therapy is unnecessary for hand surgery. J Hand Surg Br. 2004;29:203–5.PubMedCrossRef Wallace DL, Latimer MD, Belcher HJ. Stopping warfarin therapy is unnecessary for hand surgery. J Hand Surg Br. 2004;29:203–5.PubMedCrossRef
13.
go back to reference Simpson PM, Brew CJ, Whitehouse SL, Crawford RW, Donnelly BJ. Complications of perioperative warfarin therapy in total knee arthroplasty. J Arthroplasty. 2014;29:320–4.PubMedCrossRef Simpson PM, Brew CJ, Whitehouse SL, Crawford RW, Donnelly BJ. Complications of perioperative warfarin therapy in total knee arthroplasty. J Arthroplasty. 2014;29:320–4.PubMedCrossRef
14.
go back to reference Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med. 2003;163:901–8.PubMedCrossRef Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med. 2003;163:901–8.PubMedCrossRef
15.
go back to reference Hall DL. Cataract surgery and anticoagulants. J La State Med Soc. 1996;148:431–3.PubMed Hall DL. Cataract surgery and anticoagulants. J La State Med Soc. 1996;148:431–3.PubMed
16.
go back to reference Larson BJ, Zumberg MS, Kitchens CS. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. Chest. 2005;127:922–7.PubMedCrossRef Larson BJ, Zumberg MS, Kitchens CS. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk. Chest. 2005;127:922–7.PubMedCrossRef
17.
go back to reference McLemore EC, Harold KL, Cha SS, Johnson DJ, Fowl RJ. The safety of open inguinal herniorraphy in patients on chronic warfarin therapy. Am J Surg. 2006;192:860–4.PubMedCrossRef McLemore EC, Harold KL, Cha SS, Johnson DJ, Fowl RJ. The safety of open inguinal herniorraphy in patients on chronic warfarin therapy. Am J Surg. 2006;192:860–4.PubMedCrossRef
18.
go back to reference Rhodes DA, Severson EP, Hodrick JT, Dunn HK, Hofmann AA. Discontinuation of warfarin is unnecessary in total knee arthroplasty. Clin Orthop Relat Res. 2010;468:120–6.PubMedCentralPubMedCrossRef Rhodes DA, Severson EP, Hodrick JT, Dunn HK, Hofmann AA. Discontinuation of warfarin is unnecessary in total knee arthroplasty. Clin Orthop Relat Res. 2010;468:120–6.PubMedCentralPubMedCrossRef
19.
go back to reference Chana R, Salmon L, Waller A, Pinczewski L. Warfarin management in patients on continuous anticoagulation therapy undergoing total knee replacement. J Bone Joint Surg Br. 2011;93:1497–502.PubMedCrossRef Chana R, Salmon L, Waller A, Pinczewski L. Warfarin management in patients on continuous anticoagulation therapy undergoing total knee replacement. J Bone Joint Surg Br. 2011;93:1497–502.PubMedCrossRef
20.
go back to reference Han CD, Shin DE. Postoperative blood salvage and reinfusion after total joint arthroplasty. J Arthroplasty. 1997;12:511–6.PubMedCrossRef Han CD, Shin DE. Postoperative blood salvage and reinfusion after total joint arthroplasty. J Arthroplasty. 1997;12:511–6.PubMedCrossRef
21.
go back to reference Healy WL, Pfeifer BA, Kurtz SR, Johnson C, Johnson W, Johnston R, et al. Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery. Clin Orthop Relat Res. 1994;299:53–9.PubMed Healy WL, Pfeifer BA, Kurtz SR, Johnson C, Johnson W, Johnston R, et al. Evaluation of autologous shed blood for autotransfusion after orthopaedic surgery. Clin Orthop Relat Res. 1994;299:53–9.PubMed
22.
go back to reference Simpson MB, Murphy KP, Chambers HG, Bucknell AL. The effect of postoperative wound drainage reinfusion in reducing the need for blood transfusions in elective total joint arthroplasty: a prospective, randomized study. Orthopedics. 1994;17:133–7.PubMed Simpson MB, Murphy KP, Chambers HG, Bucknell AL. The effect of postoperative wound drainage reinfusion in reducing the need for blood transfusions in elective total joint arthroplasty: a prospective, randomized study. Orthopedics. 1994;17:133–7.PubMed
23.
go back to reference Slagis SV, Benjamin JB, Volz RG, Giordano GF. Postoperative blood salvage in total hip and knee arthroplasty. A randomised controlled trial. J Bone Joint Surg Br. 1991;73:591–4.PubMed Slagis SV, Benjamin JB, Volz RG, Giordano GF. Postoperative blood salvage in total hip and knee arthroplasty. A randomised controlled trial. J Bone Joint Surg Br. 1991;73:591–4.PubMed
24.
go back to reference Woolson ST, Wall WW. Autologous blood transfusion after total knee arthroplasty: a randomized, prospective study comparing predonated and postoperative salvage blood. J Arthroplasty. 2003;18:243–9.PubMedCrossRef Woolson ST, Wall WW. Autologous blood transfusion after total knee arthroplasty: a randomized, prospective study comparing predonated and postoperative salvage blood. J Arthroplasty. 2003;18:243–9.PubMedCrossRef
25.
go back to reference Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. JAMA. 1985;254:3449–53.PubMedCrossRef Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. JAMA. 1985;254:3449–53.PubMedCrossRef
26.
go back to reference Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449–1457. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449–1457.
27.
go back to reference Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2006;48:854–906.PubMedCrossRef Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol. 2006;48:854–906.PubMedCrossRef
28.
go back to reference Thakur NA, Czerwein JK, Butera JN, Palumbo MA. Perioperative management of chronic anticoagulation in orthopaedic surgery. J Am Acad Orthop Surg. 2010;18:729–38.PubMed Thakur NA, Czerwein JK, Butera JN, Palumbo MA. Perioperative management of chronic anticoagulation in orthopaedic surgery. J Am Acad Orthop Surg. 2010;18:729–38.PubMed
29.
go back to reference Brinker MR, Reuben JD, Mull JR, Cox DD, Daum WJ, Parker JR. Comparison of general and epidural anesthesia in patients undergoing primary unilateral THR. Orthopedics. 1997;20:109–15.PubMed Brinker MR, Reuben JD, Mull JR, Cox DD, Daum WJ, Parker JR. Comparison of general and epidural anesthesia in patients undergoing primary unilateral THR. Orthopedics. 1997;20:109–15.PubMed
30.
go back to reference Manolio TA, Beattie C, Christopherson R, Pearson TA. Regional versus general anesthesia in high-risk surgical patients: the need for a clinical trial. J Clin Anesth. 1989;1:414–21.PubMedCrossRef Manolio TA, Beattie C, Christopherson R, Pearson TA. Regional versus general anesthesia in high-risk surgical patients: the need for a clinical trial. J Clin Anesth. 1989;1:414–21.PubMedCrossRef
31.
go back to reference Parker MJ, Unwin SC, Handoll HH, Griffiths R. General versus spinal/epidural anaesthesia for surgery for hip fractures in adults. Cochrane Database Syst Rev. 2000;4, CD000521.PubMed Parker MJ, Unwin SC, Handoll HH, Griffiths R. General versus spinal/epidural anaesthesia for surgery for hip fractures in adults. Cochrane Database Syst Rev. 2000;4, CD000521.PubMed
Metadata
Title
Warfarin cessation is non-essential in patients undergoing total knee arthroplasty—a case-control study
Authors
Alfred Phillips
Michael Dan
Nathan Schaefer
Raymond Randle
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Journal of Orthopaedic Surgery and Research / Issue 1/2015
Electronic ISSN: 1749-799X
DOI
https://doi.org/10.1186/s13018-015-0153-4

Other articles of this Issue 1/2015

Journal of Orthopaedic Surgery and Research 1/2015 Go to the issue